ARCHIVES

New Compounds To Treat Gleevec-Resistant CML

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

DCT Board Ok’s concept For In Vivo Combination Studies

November 23, 1990

Clinical Instigator Object To HEW Proposal On Compensation Notification In Consent Forms

December 15, 1978

“Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money

February 1, 1985

Leffall New ACS President, Gudberg, President-Elect

November 17, 1978

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014